SCHEMBL25027728

SCHEMBL25027728

Bc1ccc(C(C)C)cc1C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.41
▸ TRPA1 O75762 2/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ CACNA1C Q13936 1/20 0.40
▸ ALOX12 P18054 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HTT P42858 3/20 0.39
▸ FABP3 P05413 2/20 0.39
▸ FABP4 P15090 2/20 0.39
▸ HIF1A Q16665 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ FABP5 Q01469 1/20 0.38
▸ RNASEH1 O60930 1/20 0.36
▸ TYR P14679 4/20 0.35
▸ KIF11 P52732 1/20 0.34
▸ TP53 P04637 3/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ NPC1 O15118 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25710691 0.83 LMNA (0.36) LMNATRPA1GABRA1GABRB2PTGS1
SCHEMBL24868612 0.81 LMNA (0.41) LMNATRPA1GABRA1GABRB2PTGS1
SCHEMBL19317747 0.80 LMNA (0.44) LMNATRPA1PTGS1CACNA1CALOX12
SCHEMBL778017 0.77 LMNA (0.46) LMNATRPA1GABRA1GABRB2PTGS1
SCHEMBL29630154 0.77 LMNA (0.46) LMNATRPA1GABRA1GABRB2PTGS1
SCHEMBL10227597 0.76 LMNA (0.52) LMNATRPA1PTGS1CACNA1CALOX12
SCHEMBL16511366 0.74 LMNA (0.40) LMNATRPA1PTGS1CACNA1CALOX12
SCHEMBL23771856 0.74 RECQL (0.36) LMNATRPA1GABRA1GABRB2PTGS1
SCHEMBL22618958 0.74 LMNA (0.40) LMNATRPA1PTGS1CACNA1CALOX12
SCHEMBL11063120 0.74 LMNA (0.40) LMNATRPA1GABRA1GABRB2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230049402-A1 NOVEL PHENOL COMPOUND OR SALT THEREOF TAIHO PHARMACEUTICAL CO. LTD. (JP) 2023-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230049402-A1 NOVEL PHENOL COMPOUND OR SALT THEREOF MYB, MLX, EP300 LMNA 2792/4885TRPA1 1249/4885GABRA1 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback